Home > Insider Trading > Filing (0001415889-22-011708)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1798749	Aerovate Therapeutics Inc.	AVTE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413006	A George Eldridge	C/O Aerovate Therapeutics, Inc. 930 Winter Street, Suite M-500 Waltham MA 02451	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-11-18	861	$2.14	2,821	No	4	M	Direct
Common Stock	Disposition	2022-11-18	780	$19.45	2,041	No	4	S	Direct
Common Stock	Disposition	2022-11-18	81	$20.13	1,960	No	4	S	Direct
Common Stock	Acquisiton	2022-11-21	2	$2.14	1,962	No	4	M	Direct
Common Stock	Disposition	2022-11-21	2	$19.00	1,960	No	4	S	Direct
Common Stock	Acquisiton	2022-11-22	174	$2.14	2,134	No	4	M	Direct
Common Stock	Disposition	2022-11-22	174	$19.01	1,960	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-11-18	861	$0.00	861	$2.14
Common Stock	Stock Option (Right to Buy)	Disposition	2022-11-21	2	$0.00	2	$2.14
Common Stock	Stock Option (Right to Buy)	Disposition	2022-11-22	174	$0.00	174	$2.14

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
97,815	2031-04-01	No	4	M	Direct
97,813	2031-04-01	No	4	M	Direct
97,639	2031-04-01	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.
Includes 1,960 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.06 to $20.045, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.095 to $20.29, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.03, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.